Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Health status measurement in chronic obstructive pulmonary disease.

Literature DB >> 11641515

Health status measurement in chronic obstructive pulmonary disease.

Abstract

Health status measurement is a common feature of studies in chronic obstructive pulmonary disease (COPD). This review assesses recent evidence for the validity of these measurements and their role as measures of the overall impact of the disease on the patient's daily life and wellbeing. It reviews the mostly widely used COPD specific questionnaires and examines the contribution that they make to an assessment of the overall effect of treatment. Finally, it addresses the question of how symptomatic benefit may be assessed in individual patients in routine practice.

Entities: Disease Species

Mesh：

Year: 2001 PMID： 11641515 PMCID： PMC1745959 DOI： 10.1136/thorax.56.11.880

Source DB: PubMed Journal: Thorax ISSN： 0040-6376 Impact factor: 9.139

60 in total

1. Dyspnea and leg effort during incremental cycle ergometry.

Authors: K J Killian; E Summers; N L Jones; E J Campbell
Journal: Am Rev Respir Dis Date: 1992-06

2. Quality of life in patients with chronic respiratory disease: the Spanish version of the Chronic Respiratory Questionnaire (CRQ)

Authors: R Güell; P Casan; M Sangenís; F Morante; J Belda; G H Guyatt
Journal: Eur Respir J Date: 1998-01 Impact factor: 16.671

3. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial.

Authors: P S Burge; P M Calverley; P W Jones; S Spencer; J A Anderson; T K Maslen
Journal: BMJ Date: 2000-05-13

4. A comparison of global questions versus health status questionnaires as measures of the severity and impact of asthma.

Authors: E A Barley; P W Jones
Journal: Eur Respir J Date: 1999-09 Impact factor: 16.671

5. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial.

Authors: T L Griffiths; M L Burr; I A Campbell; V Lewis-Jenkins; J Mullins; K Shiels; P J Turner-Lawlor; N Payne; R G Newcombe; A A Ionescu; J Thomas; J Tunbridge; A A Lonescu
Journal: Lancet Date: 2000-01-29 Impact factor: 79.321

6. Domains, constructs and the development of the breathing problems questionnaire.

Authors: M E Hyland; J Bott; S Singh; C A Kenyon
Journal: Qual Life Res Date: 1994-08 Impact factor: 4.147

7. Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in out-patients with COPD.

Authors: M P Engelen; A M Schols; W C Baken; G J Wesseling; E F Wouters
Journal: Eur Respir J Date: 1994-10 Impact factor: 16.671

8. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease.

Authors: M J Belman; W C Botnick; J W Shin
Journal: Am J Respir Crit Care Med Date: 1996-03 Impact factor: 21.405

9. Peripheral muscle weakness contributes to exercise limitation in COPD.

Authors: R Gosselink; T Troosters; M Decramer
Journal: Am J Respir Crit Care Med Date: 1996-03 Impact factor: 21.405

10. Nasal pressure support ventilation plus oxygen compared with oxygen therapy alone in hypercapnic COPD.

Authors: D J Meecham Jones; E A Paul; P W Jones; J A Wedzicha
Journal: Am J Respir Crit Care Med Date: 1995-08 Impact factor: 21.405

116 in total

1. Health status measurement: sensitivity of the self-reported Chronic Respiratory Questionnaire (CRQ-SR) in pulmonary rehabilitation.

Authors: J E A Williams; S J Singh; L Sewell; M D L Morgan
Journal: Thorax Date: 2003-06 Impact factor: 9.139

2. Not quite a breath of fresh air: use of combination inhalers in COPD.

Authors: Sarah Stabler; Aaron M Tejani; Nicole Bruchet
Journal: Can Fam Physician Date: 2012-02 Impact factor: 3.275

3. Peak expiratory flow as a surrogate for health related quality of life in chronic obstructive pulmonary disease: a preliminary cross sectional study.

Authors: D O Obaseki; M O Akanbi; C C Onyedum; O B Ozoh; J Jumbo; A A Akor; G E Erhabor
Journal: Ghana Med J Date: 2014-06

4. Drug management of COPD.

Authors: Peter D Burrill
Journal: BMJ Date: 2007-04-28

5. Respiratory effects of secondhand smoke exposure among young adults residing in a "clean" indoor air state.

Authors: David J Lee; Noella A Dietz; Kristopher L Arheart; James D Wilkinson; John D Clark; Alberto J Caban-Martinez
Journal: J Community Health Date: 2008-06

6. Airway wall attenuation: a biomarker of airway disease in subjects with COPD.

Authors: George R Washko; Mark T Dransfield; Raúl San José Estépar; Alejandro Diaz; Shin Matsuoka; Tsuneo Yamashiro; Hiroto Hatabu; Edwin K Silverman; William C Bailey; John J Reilly
Journal: J Appl Physiol (1985) Date: 2009-04-30

7. Long-Term Evaluation of the Effects of Aclidinium Bromide on Major Adverse Cardiovascular Events and COPD Exacerbations in Patients with Moderate to Very Severe COPD: Rationale and Design of the ASCENT COPD Study.

Authors: Robert A Wise; Kenneth R Chapman; Benjamin M Scirica; David A Schoenfeld; Deepak L Bhatt; Sami Z Daoud; Beatriz Seoane; Colin Reisner; Esther Garcia Gil
Journal: Chronic Obstr Pulm Dis Date: 2018-01-24